Weight gain is common after the initiation of ART and may reduce the risk for mortality in patients with HIV infection who previously had normal to low BMI. However, patients with overweight or ...

Weight gain associated with integrase strand transfer inhibitor-based antiretroviral therapy (ART) may be mitigated or reversed over time by switching to protease inhibitor-based ART. For patients ...

ART is crucial for HIV management but can lead to significant weight gain, affecting quality of life and adherence. A study found 24% of participants experienced a 5% or greater weight gain, ...

Adults with HIV and obesity who switched from an antiretroviral therapy (ART) regimen with an integrase strand transfer inhibitor (INSTI) and tenofovir alafenamide to doravirine with or without ...